Donaldson Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Buy
88,678
+14,715
+20% +$15M 3.04% 7
2026
Q1
$68M Buy
73,963
+6,055
+9% +$6.14M 2.2% 14
2025
Q4
$73M Buy
67,908
+42,534
+168% +$40.7M 2.32% 12
2025
Q3
$19.4M Buy
25,374
+2,607
+11% +$1.94M 0.61% 34
2025
Q2
$17.7M Sell
22,767
-841
-4% -$654K 0.65% 35
2025
Q1
$19.5M Buy
23,608
+326
+1% +$271K 0.74% 35
2024
Q4
$18M Buy
23,282
+476
+2% +$394K 0.69% 34
2024
Q3
$20.2M Sell
22,806
-3,247
-12% -$2.92M 0.78% 35
2024
Q2
$23.6M Buy
26,053
+423
+2% +$338K 0.99% 35
2024
Q1
$19.9M Buy
25,630
+2,651
+12% +$1.89M 0.83% 35
2023
Q4
$13.4M Sell
22,979
-17,292
-43% -$10.1M 0.6% 36
2023
Q3
$21.6M Sell
40,271
-203
-0.5% -$105K 1.02% 36
2023
Q2
$19M Sell
40,474
-1,307
-3% -$548K 0.87% 34
2023
Q1
$14.3M Sell
41,781
-5,314
-11% -$1.79M 0.68% 36
2022
Q4
$17.2M Buy
47,095
+2,561
+6% +$908K 0.84% 34
2022
Q3
$14.4M Buy
44,534
+2,550
+6% +$808K 0.79% 35
2022
Q2
$13.6M Sell
41,984
-63
-0.1% -$18.9K 0.7% 37
2022
Q1
$12M Buy
42,047
+574
+1% +$148K 0.55% 39
2021
Q4
$11.5M Sell
41,473
-453
-1% -$115K 0.5% 42
2021
Q3
$9.69M Sell
41,926
-301
-0.7% -$74.3K 0.49% 43
2021
Q2
$9.69M Sell
42,227
-6,570
-13% -$1.32M 0.5% 45
2021
Q1
$9.12M Buy
48,797
+598
+1% +$117K 0.5% 43
2020
Q4
$8.14M Sell
48,199
-193
-0.4% -$28.8K 0.48% 40
2020
Q3
$7.16M Sell
48,392
-1,088
-2% -$168K 0.48% 39
2020
Q2
$8.12M Buy
49,480
+918
+2% +$141K 0.59% 38
2020
Q1
$6.74M Buy
48,562
+2,522
+5% +$347K 0.59% 36
2019
Q4
$6.05M Buy
46,040
+20,705
+82% +$2.4M 0.41% 47
2019
Q3
$2.83M Buy
25,335
+19,745
+353% +$2.2M 0.21% 64
2019
Q2
$619K Buy
5,590
+176
+3% +$20.7K 0.05% 99
2019
Q1
$703K Sell
5,414
-720
-12% -$87.6K 0.06% 91
2018
Q4
$710K Sell
6,134
-150
-2% -$16.8K 0.07% 92
2018
Q3
$674K Sell
6,284
-107
-2% -$10.7K 0.06% 99
2018
Q2
$545K Sell
6,391
-100
-2% -$8.21K 0.05% 104
2018
Q1
$502K Sell
6,491
-350
-5% -$28.2K 0.05% 108
2017
Q4
$578K Buy
6,841
+413
+6% +$35.1K 0.06% 106
2017
Q3
$550K Buy
6,428
+100
+2% +$8.2K 0.06% 102
2017
Q2
$521K Sell
6,328
-300
-5% -$24.5K 0.06% 104
2017
Q1
$557K Sell
6,628
-400
-6% -$32K 0.06% 102
2016
Q4
$517K Buy
7,028
+54
+0.8% +$4.02K 0.06% 101
2016
Q3
$560K Sell
6,974
-7
-0.1% -$560 0.07% 88
2016
Q2
$550K Buy
6,981
+112
+2% +$8.43K 0.08% 88
2016
Q1
$495K Hold
6,869
0.07% 90
2015
Q4
$579K Buy
6,869
+105
+2% +$8.71K 0.08% 87
2015
Q3
$566K Sell
6,764
-2,800
-29% -$236K 0.08% 88
2015
Q2
$799K Sell
9,564
-2,200
-19% -$168K 0.11% 74
2015
Q1
$855K Buy
11,764
+1,950
+20% +$139K 0.12% 70
2014
Q4
$677K Buy
9,814
+1,000
+11% +$67.5K 0.1% 82
2014
Q3
$572K Hold
8,814
0.09% 82
2014
Q2
$548K Buy
8,814
+72
+0.8% +$4.3K 0.09% 84
2014
Q1
$515K Buy
8,742
+88
+1% +$4.91K 0.09% 77
2013
Q4
$441K Buy
8,654
+2,400
+38% +$120K 0.09% 74
2013
Q3
$315K Sell
6,254
-200
-3% -$10.5K 0.07% 79
2013
Q2
$317K Buy
+6,454
New +$351K 0.07% 71

Other funds holding LLY

Donaldson Capital Management's LLY Position: Q2 2026 in Review

Donaldson Capital Management increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $15M and bringing the position to 88,678 shares worth $106M. The position accounts for 3.04% of the portfolio, ranked #7.

Donaldson Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Donaldson Capital Management held 88,678 shares of Eli Lilly worth $106M as of Q2 2026.
  • Donaldson Capital Management bought 14,715 Eli Lilly shares in Q2 2026, an estimated $15M.
  • Eli Lilly made up 3.04% of Donaldson Capital Management's portfolio in Q2 2026, its #7 holding.
  • Donaldson Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Donaldson Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.